83408-81-5 Usage
Uses
Used in Pharmaceutical Industry:
MBZ is used as an antiparasitic and anthelmintic agent for treating infections caused by worms and parasites due to its benzimidazole derivative nature.
Used in Oncology:
MBZ is used as an anticancer agent for inhibiting the proliferation of cancer cells, making it a potential candidate for cancer treatment.
Used in Inflammation Management:
MBZ is used as an anti-inflammatory agent for managing inflammation-related conditions.
Used in Neurodegenerative Disease Treatment:
MBZ is being investigated for its potential use in treating neurodegenerative diseases, suggesting its possible neuroprotective properties.
Used in Antiviral Applications:
MBZ is being explored as an antiviral agent, indicating its potential to combat viral infections.
Used in Drug Discovery and Development:
MBZ's unique molecular structure and properties make it a valuable compound for drug discovery and development in the pharmaceutical industry, broadening its potential applications in various therapeutic areas.
Check Digit Verification of cas no
The CAS Registry Mumber 83408-81-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,3,4,0 and 8 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 83408-81:
(7*8)+(6*3)+(5*4)+(4*0)+(3*8)+(2*8)+(1*1)=135
135 % 10 = 5
So 83408-81-5 is a valid CAS Registry Number.
InChI:InChI=1/C16H15N3O2S/c1-21-14-9-5-4-8-13(14)17-10-15(20)22-16-18-11-6-2-3-7-12(11)19-16/h2-9,17H,10H2,1H3,(H,18,19)
83408-81-5Relevant academic research and scientific papers
Synthesis and CNS Activity of 2-(N-Arylaminoacetylmercapto)- and 2-(N-Arylacetamidomercapto)-benzimidazoles
Tripathi, Shephali,Ahmad, Shakeel,Barthwal, J. P.,Kishor, K.,Tangri, K. K.,Bhargava, K. P.
, p. 379 - 380 (2007/10/02)
The title mercaptobenzimidazoles (1a-t) have been synthesised and screened for their anticonvulsant and monoamine oxidase (MAO) inhibitory activities.Some of the compounds provide 80percent protection against pentylenetetrazole-induced convulsions and max
